These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. Zhang M; Zhang Z; Garmestani K; Schultz J; Axworthy DB; Goldman CK; Brechbiel MW; Carrasquillo JA; Waldmann TA Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1891-5. PubMed ID: 12569172 [TBL] [Abstract][Full Text] [Related]
23. [Antibody Engineering: From the Idea to Its Implementation]. Polanovsky OL Mol Biol (Mosk); 2017; 51(6):1039-1045. PubMed ID: 29271966 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody-based therapy of lymphoid neoplasms: what's on the horizon? Davis AT Semin Hematol; 2000 Oct; 37(4 Suppl 7):34-42. PubMed ID: 11147488 [TBL] [Abstract][Full Text] [Related]
26. [Use of antibodies or their fragments for the treatment of tumors]. Douillard JY; Chatal JF Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody treatment of solid tumors: a coming of age. Murray JL Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030 [TBL] [Abstract][Full Text] [Related]
28. [Antibody therapy in hematology and oncology - part 1]. Kneba M; Schrader C; Köhne H Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214 [No Abstract] [Full Text] [Related]
30. Immunotherapy for cancer: construction, expression and functional characterization of chimeric antibodies. Motmans K; Thirion S; Heyligen H; Janssens J; Raus J; Vandevyver C Eur J Cancer Prev; 1996 Dec; 5(6):512-9. PubMed ID: 9061286 [TBL] [Abstract][Full Text] [Related]
31. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies]. Oriuchi N Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144 [TBL] [Abstract][Full Text] [Related]
32. [Monoclonal antibodies and therapeutics]. Desgranges C Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379 [TBL] [Abstract][Full Text] [Related]
37. Engineering antibodies for therapy. Adair JR Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872 [TBL] [Abstract][Full Text] [Related]
38. Current status of therapy of solid tumors. Jhanwar YS; Divgi C J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662 [TBL] [Abstract][Full Text] [Related]
39. [Ten years since the successful introduction of the first monoclonal antibody (rituximab) into the therapy of lymphomas]. Trnený M; Klener P Cas Lek Cesk; 2007; 146(7):578-85. PubMed ID: 17722844 [TBL] [Abstract][Full Text] [Related]
40. Engineered affinity proteins for tumour-targeting applications. Friedman M; Ståhl S Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]